文献速递心血管CTDSA

光子计数探测器CT虚拟单能图像用于冠状动脉狭窄定量:体模与在体评估

Photon-Counting Detector CT Virtual Monoenergetic Images for Coronary Artery Stenosis Quantification: Phantom and In Vivo Evaluation.
PubMed 文献 · AJR Am J Roentgenol · 2024-01-10

本研究通过体模和33例患者(64处冠状动脉狭窄)评估光子计数探测器CT虚拟单能成像(VMI)重建能级对冠状动脉狭窄定量的影响。随VMI能级升高,钙化和混合斑块的狭窄程度测量值及钙化晕状伪影均降低;非钙化斑块则呈相反趋势。结论提示VMI重建有助于克服冠状动脉CTA狭窄定量的现有局限。

要点

  • 钙化和混合斑块的狭窄程度测量值随VMI能级升高而降低,钙化晕状伪影亦减轻。
  • 体模中25%狭窄在90 keV偏倚最小(1.4%),50%狭窄在100 keV偏倚最小(-0.4%)。
  • 患者钙化斑块在100 keV偏倚最小(17.2%),混合斑块在140 keV最小(5.0%),非钙化斑块在40 keV最小(-0.5%)。

核心结论

  • 对于钙化和混合斑块,随VMI重建能级升高,狭窄严重程度测量值和钙化晕状伪影均降低;光子计数探测器CT结合VMI重建有助于克服当前冠状动脉CTA狭窄定量的局限。

研究设计与样本

  • 体模研究结合回顾性分析,体模含两条自定义血管(分别代表25%和50%狭窄),在无和模拟心脏运动条件下行光子计数探测器CT采集;患者为33例(女7例、男26例,平均年龄71.3±9.0岁)共64处冠状动脉狭窄,行光子计数探测器CT冠状动脉CTA后接受有创冠状动脉造影(ICA)。

关键影像表现/征象

  • 体模中25%狭窄的直径狭窄百分比从40 keV的59.9%降至140 keV的13.4%,50%狭窄从40 keV的81.6%降至140 keV的42.3%。
  • 体模中25%狭窄的晕状伪影从40 keV的61.5%降至140 keV的35.4%,50%狭窄从40 keV的82.7%降至140 keV的52.1%。
  • 患者钙化斑块的直径狭窄百分比从40 keV的70.8%降至140 keV的57.3%,混合斑块从40 keV的69.8%降至140 keV的56.3%。
  • 患者非钙化斑块的直径狭窄百分比在40 keV为46.6%、在140 keV为54.6%。
  • 患者钙化斑块的晕状伪影从40 keV的78.4%降至140 keV的48.6%,混合斑块从40 keV的73.1%降至140 keV的44.7%。

诊断标准与关键数值

  • 体模中25%狭窄的直径狭窄百分比偏倚在90 keV最低(偏倚1.4%),50%狭窄在100 keV最低(偏倚-0.4%)。
  • 患者钙化斑块的直径狭窄百分比偏倚在100 keV最低(偏倚17.2%),混合斑块在140 keV最低(偏倚5.0%),非钙化斑块在40 keV最低(偏倚-0.5%)。
  • 重建能级共9个(40-140 keV),直径狭窄百分比以体模真实狭窄百分比和ICA定量冠状动脉造影测量为参考标准计算偏倚。

临床应用与阅片要点

  • 对于钙化和混合斑块,选用较高VMI重建能级可降低狭窄程度测量值和钙化晕状伪影。
  • 非钙化斑块的直径狭窄百分比随VMI能级升高而升高,与钙化和混合斑块的变化方向相反。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. Calcium blooming causes stenosis overestimation on coronary CTA. OBJECTIVE. The purpose of this article was to evaluate the impact of virtual monoenergetic imaging (VMI) reconstruction level on coronary artery stenosis quantification using photon-counting detector (PCD) CT. METHODS. A phantom containing two custom-made vessels (representing 25% and 50% stenosis) underwent PCD CT acquisitions without and with simulated cardiac motion. A retrospective analysis was performed of 33 patients (seven women, 26 men; mean age, 71.3 ± 9.0 [SD] years; 64 coronary artery stenoses) who underwent coronary CTA by PCD CT followed by invasive coronary angiography (ICA). Scans were reconstructed at nine VMI energy levels (40-140 keV). Percentage diameter stenosis (PDS) was measured, and bias was determined from the ground-truth stenosis percentage in the phantom and ICA-derived quantitative coronary angiography measurements in patients. Extent of blooming artifact was measured in the phantom and in calcified and mixed plaques in patients. RESULTS. In the phantom, PDS decreased for 25% stenosis from 59.9% (40 keV) to 13.4% (140 keV) and for 50% stenosis from 81.6% (40 keV) to 42.3% (140 keV). PDS showed lowest bias for 25% stenosis at 90 keV (bias, 1.4%) and for 50% stenosis at 100 keV (bias, -0.4%). Blooming artifacts decreased for 25% stenosis from 61.5% (40 keV) to 35.4% (140 keV) and for 50% stenosis from 82.7% (40 keV) to 52.1% (140 keV). In patients, PDS for calcified plaque decreased from 70.8% (40 keV) to 57.3% (140 keV), for mixed plaque decreased from 69.8% (40 keV) to 56.3% (140 keV), and for noncalcified plaque was 46.6% at 40 keV and 54.6% at 140 keV. PDS showed lowest bias for calcified plaque at 100 keV (bias, 17.2%), for mixed plaque at 140 keV (bias, 5.0%), and for noncalcified plaque at 40 keV (bias, -0.5%). Blooming artifacts decreased for calcified plaque from 78.4% (40 keV) to 48.6% (140 keV) and for mixed plaque from 73.1% (40 keV) to 44.7% (140 keV). CONCLUSION. For calcified and mixed plaque, stenosis severity measurements and blooming artifacts decreased at increasing VMI reconstruction levels. CLINICAL IMPACT. PCD CT with VMI reconstruction helps overcome current limitations in stenosis quantification on coronary CTA.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Wolf EV, Halfmann MC, Varga-Szemes A, et al. Photon-Counting Detector CT Virtual Monoenergetic Images for Coronary Artery Stenosis Quantification: Phantom and In Vivo Evaluation. AJR Am J Roentgenol. 2024. PMID: 38197760. doi:10.2214/AJR.23.30481

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。